News & Media: overview

The latest news from Visante

James Jorgenson – senior executive, pharmacist, researcher and sought-after speaker

Point of view: most recent

  • Edaravone: 1st New ALS Treatment Option in 25 Years

    Published in May 2018, the supplement to The American Journal of Managed Care® (available here), entitled “Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy—A Roundtable Discussion,” reviews the therapeutic spectrum for amyotrophic lateral sclerosis (ALS) …

  • 340B Regulatory and Legislative Update

    In the January 2018 Point of View, we discussed threats that the 340B Program is facing in 2018.

    We also provided an overview of changes that have already occurred, as well as identified new threats the 340B Program is …

  • Barbara Bush – An Educator to the End

    On April 17th, the country lost one of our most beloved first ladies and citizens when Mrs. Barbara Bush, who was suffering from COPD and CHF, passed away.  No matter political affiliation Mrs. Bush was an individual that …

  • Road to USP <800> Compliance: Section 9

    Section 9 Personal Training

    Sections 1 through 8 of United States Pharmacopeia (USP) Chapter 800: Hazardous Drugs—Handling in Healthcare Settings are the blueprint and engineering structures with checks and balances for quality control. They also provide direct protective measures on …